Correction: ERManI Is a Target of miR-125b and Promotes Transformation Phenotypes in Hepatocellular Carcinoma (HCC).
oleh: Shujuan Pan, Xiaoyun Cheng, Hongan Chen, Patricia D. Castro, Michael M. Ittmann, Anne W. Hutson, Susan K. Zapata, Richard N. Sifers
| Format: | Article |
|---|---|
| Diterbitkan: | Public Library of Science (PLoS) 2014-01-01 |
Deskripsi
No description available for this item.